OKE vs TVRD · P/E 15, rev $21.70B vs rev $7.1M
ONEOK Inc (OKE) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Latest reported TVRD revenue for 2024-12-31 was $7.1M. Net income was -$70.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. TVRD currently screens at market cap $0.
OKE currently screens at market cap $53.92B and trailing P/E 15.3. TVRD currently screens at market cap $0.
Not investment advice. Open the OKE and TVRD stock pages for the full models.
Not investment advice.